The Indian pharmaceutical industry will become self-reliant in the next two–three years, Serum Institute of India Pvt.'s Chief Executive Officer Adar Poonawalla said.
Though the pharmaceutical companies are currently dependent on China for active pharmaceutical ingredients and raw materials, they have now begun shifting to local productions, Poonawalla said.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
"The cost of some of these drugs may increase as a result," he told BQ Prime's Niraj Shah, on the sidelines of the World Economic Forum in Davos.
As the coronavirus cases in India continue to fall, SII is focusing on developing non-Covid vaccines for diseases like malaria and human papillomavirus or the HPV Infection.
"We have dengue vaccines coming in about two–three years. We hope to roll out a vaccine for five strains of the meningitis bacterial disease that plagues the African continent also," Poonawalla said.
The government's quick regulatory clearances and streamlined procedures have aided the company in "creating newer drugs and innovating much faster", he said.
"It's an exciting time to be a company working and investing in India," Poonawalla said.
Lending And Insurance Business
With the growth of digitisation in India, it has become easier to run a digitised non-banking finance company, in terms of dispensing loans, offering other services and collecting the money, Poonawalla said.
He expects continued credit growth in India.
The company's health insurance business complements its healthcare business, and there are plans to provide "affordable, widespread and good" health insurance to the people in India, he said.
Watch the full interview here:
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.